# Lexicon Pharmaceuticals to Participate in Three Upcoming March Investor Conferences
Canonical URL: https://biopharmsignal.com/news/LXRX/lexicon-pharmaceuticals-to-participate-in-three-upcoming-march-investor-conferen-d9c2f3ad
Ticker: LXRX
Company: Lexicon Pharmaceuticals
Source: Lexicon Pharmaceuticals
Published: 2026-03-03 21:01 EST
## Summary

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will...

## Article Body
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in an upcoming fireside chat at the 2026 Leerink Partners Global Healthcare Conference in Miami on Wednesday, March 11, at 10:00 a.m.

Lexicon will also be participating in 1x1 investor meetings at the 2026 Jefferies Biotech on the Beach Summit , March 10–11, and at the Barclays 28th Global Healthcare Conference, March 10-12.

A live recording and replay of the Leerink fireside chat can be accessed via the Events page of the Company’s website at https://investors.lexpharma.com/ .

About Lexicon Pharmaceuticals Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Lexicon has a pipeline of drug candidates in discovery, preclinical, and clinical development in neuropathic pain, hypertrophic cardiomyopathy (HCM), obesity and metabolic disorders, and other cardiometabolic indications. For additional information, please visit www.lexpharma.com .

For Investor and Media Inquiries : Lisa DeFrancesco Lexicon Pharmaceuticals, Inc. lexinvest@lexpharma.com
## Recent Company News
- 2026-07-27 12:30 EST — [Lexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and Obstructive Hypertrophic Cardiomyopathy (HCM)](https://biopharmsignal.com/news/LXRX/lexicon-pharmaceuticals-completes-enrollment-of-pivotal-phase-3-sonata-hcm-study-684930b3) — Source: Lexicon Pharmaceuticals
- 2026-06-03 12:00 EST — [Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessions](https://biopharmsignal.com/news/LXRX/lexicon-to-present-data-at-the-american-diabetes-association-ada-2026-scientific-60360dc3) — Source: Lexicon Pharmaceuticals
- 2026-05-28 12:30 EST — [Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference](https://biopharmsignal.com/news/LXRX/lexicon-pharmaceuticals-to-present-at-the-2026-jefferies-global-healthcare-confe-9895b44d) — Source: Lexicon Pharmaceuticals
- 2026-05-12 12:30 EST — [Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference](https://biopharmsignal.com/news/LXRX/lexicon-pharmaceuticals-to-present-at-the-4th-annual-h-c-wainwright-bioconnect-i-e7889bc9) — Source: Lexicon Pharmaceuticals
- 2026-05-07 11:30 EST — [Lexicon Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Clinical Updates](https://biopharmsignal.com/news/LXRX/lexicon-pharmaceuticals-reports-first-quarter-2026-financial-results-and-provide-4b7317fd) — Source: Lexicon Pharmaceuticals
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)